Medication info
Atacan Tablet 32 mg (Candesartan Cilexetil)

Atacan Tablet 32 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›32mg / 1 tablet
Manufacturer / importer
DKSH Korea Ltd.
Appearance
Pink, round, biconvex tablet
Packaging
30 tablets (10 tablets / PTP × 3)
Approval status
Active

MFDS item code 200511255 · Approved 2005.04.13 · Insurance code 055500130

Summary

Main use
Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time each day, regardless of meals. Essential hypertension — Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled with this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Essential hypertension — Elderly patients: No initial dose adjustment is necessary. Essential hypertension — Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful caution. Essential hypertension — Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). Essential hypertension — Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. Heart failure — Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of 2 weeks or longer and increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. Heart failure — Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No initial dose adjustment is necessary.
Child dose
Essential hypertension — Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure — Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Importer
DKSH Korea Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with left ventricular systolic dysfunction

  • Essential hypertension
  • heart failure
  • left ventricular dysfunction
  • decreased left ventricular ejection fraction
View approved original text

This medication is mainly used to control blood pressure in patients with essential hypertension. It is also effectively used in patients with heart failure, particularly when there is left ventricular dysfunction (heart failure NYHA class II-IV, left ventricular ejection fraction ≤ 40%) where additional therapy with an ACE inhibitor is needed or when ACE inhibitors cannot be used. This drug helps improve heart function and alleviate symptoms of heart failure. Consequently, it is used for the treatment of essential hypertension and certain heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time each day, regardless of meals. Essential hypertension — Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled with this dose, other treatment options should be considered. The maximum effect is achieved within 4 weeks of starting treatment. Essential hypertension — Elderly patients: No initial dose adjustment is necessary. Essential hypertension — Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful caution. Essential hypertension — Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. There is limited experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min). Essential hypertension — Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. Heart failure — Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of 2 weeks or longer and increased to a maximum of 32 mg once daily, taking the patient's tolerability into account. Heart failure — Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No initial dose adjustment is necessary.

Child dose

Essential hypertension — Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. Heart failure — Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This drug can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters. Therefore, it should be discontinued immediately if pregnancy is confirmed. People with allergies to this drug or its components, pregnant women or those planning to become pregnant, nursing mothers, patients with severe liver dysfunction, and those with certain genetic diseases should not take this drug. Elderly patients or those with impaired kidney function or heart disease should use this drug with special caution, and it is important to regularly monitor blood pressure, kidney function, and blood potassium levels. This drug may cause side effects such as dizziness, back pain, and respiratory infections. Rarely, it may lead to blood abnormalities, liver dysfunction, or severe allergic reactions. If any unusual symptoms occur, consult a healthcare professional immediately. Interactions may occur if taken with other antihypertensives, certain diuretics, or potassium supplements, so inform your doctor of any other medications you are taking. During treatment with this drug, be cautious as it may cause dizziness when driving or operating machinery. It is recommended that women who are pregnant or breastfeeding refrain from taking this drug; if it is absolutely necessary, breastfeeding should be discontinued. Safety and efficacy for children and adolescents under 18 years have not been established. In case of overdose, symptoms such as hypotension, dizziness, and rapid heartbeat may occur, and immediate medical attention should be sought. This drug should be kept out of reach of children, and transferring the medication to other containers is not safe and should be avoided.

Side effects

  • Dizziness
  • lower back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • altered perception
  • dyspepsia
Show 72 more
  • gastritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased perspiration
  • hematuria
  • hypotension
  • hyperkalemia
  • kidney function impairment
  • increased creatinine
  • increased urea
  • increased potassium
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • headache
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • liver dysfunction
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • increased muscle tone
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbance
  • decreased libido
  • amnesia
  • anorexia
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly sealed container to prevent exposure to air or moisture, and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the drug's efficacy and prevent degradation.

Appearance and packaging

Appearance

Pink, round, biconvex tablet

Package unit

30 tablets (10 tablets / PTP × 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.